Pharma Industry Threatened by Spike in Fees and Turkish Competition
The pharmaceutical industry in Syria, once seen as a cornerstone of the national economy and one of the most resilient industrial sectors, lost significant capacity during the 14-year old conflict, and in the aftermath of the fall of the regime now faces considerable challenges, among them a significant hike in fees.
Standard subscription Membership Required
You must be a Standard subscription member to access this content.
Already a member? Log in here
